Systems are being developed that utilize algorithms to predict impending hypoglycemia using commercially available continuous glucose monitoring (CGM) devices and to discontinue insulin delivery if hypoglycemia is predicted. In outpatient studies designed to test such systems, CGM-measured glycemic indices will not only be important outcome measures of efficacy but, in certain cases, will be the only good outcome. This is especially true in short-term studies designed to reduce hypoglycemia since the event rate for severe hypoglycemic events is too low for it to be a good outcome, and milder hypoglycemia often will be variably detected. Continuous glucose monitoring inaccuracy can be accounted for in the study design by increasing sample size and/or study duration.
TsalikianEMaurasNBeckRWTamborlaneWVJanzKFChaseHPWysockiTWeinzimerSABuckinghamBAKollmanCXingDRuedyKJ; Diabetes Research In Children Network DirecNet Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr. 2005; 147 (4): 528–34.
2.
RajuBArbelaezAMBreckenridgeSMCryerPE. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab. 2006; 91 (6): 2087–92.
3.
BuckinghamBBlockJBurdickJKalajianAKollmanCChoyMWilsonDMChaseP; Diabetes Research in Children Network. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther. 2005; 7 (3): 440–7.
4.
The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 1991; 90: 450–9.
5.
DavisEAKeatingBByrneGCRussellMJonesTW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care. 1997; 20 (1): 22–5.
6.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010; 33 (5): 1004–8.
7.
The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997; 46 (2): 271–86.
8.
ChaseHPBeckRTamborlaneWBuckinghamBMaurasNTsalikianEWysockiTWeinzimerSKollmanCRuedyKXingD. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care. 2005; 28 (5): 1101–6.
9.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Fiallo-ScharerRChengJBeckRWBuckinghamBAChaseHPKollmanCLaffelLLawrenceJMMaurasNTamborlaneWVWilsonDMWolpertH. Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care. 2010; 34 (3): 586–90.
10.
BergenstalRMTamborlaneWVAhmannABuseJBDaileyGDavisSNJoyceCPeoplesTPerkinsBAWelshJBWilliSMWoodMA; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363 (4): 311–20.
11.
Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005; 28 (5): 1245–9.
12.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, FoxLABeckRWXingD. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care. 2010; 33 (6): 1297–9.
13.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, TamborlaneWVBeckRWBodeBWBuckinghamBChaseHPClemonsRFiallo-ScharerRFoxLAGilliamLKHirschIBHuangESKollmanCKowalskiAJLaffelLLawrenceJMLeeJMaurasNO'GradyMRuedyKJTanseyMTsalikianEWeinzimerSWilsonDMWolpertHWysockiTXingD. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359 (14): 1464–76.
